Recognition of human milk oligosaccharides by bacterial exotoxins
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The affinities of the most abundant oligosaccharides found in human milk for four bacterial exotoxins (from Vibrio cholerae and pathogenic Escherichia coli) were quantified for the first time. Association constants (Ka) for a library of 20 human milk oligosaccharides (HMOs) binding to Shiga toxin type 2 holotoxin (Stx2) and the B subunit homopentamers of cholera toxin, heat-labile toxin and Shiga toxin type 1 (CTB5, HLTB5 and Stx1B5) were measured at 25°C and pH 7 using the direct electrospray ionization mass spectrometry assay. Notably, all four bacterial toxins bind to a majority of the HMOs tested and five of the HMOs (2'-fucosyllactose, lacto-N-tetraose, lacto-N-fucopentaose I, lacto-N-fucopentaose II and lacto-N-fucopentaose III) are ligands for all four toxins. These five HMOs are also reported to bind to other bacterial toxins (e.g. toxin A and toxin B of Clostridium difficile). In all cases, the HMO affinities (apparent Ka) are relatively modest (≤15,000 M(-1)). However, at the high concentrations of HMOs typically ingested by infants, a significant fraction of these toxins, if present, is expected to be bound to HMOs. Binding measurements carried out with 2'-fucosyllactose or lacto-N-fucopentaose I, together with a high-affinity ligand based on the native carbohydrate receptor, revealed that all four toxins possess HMO-binding sites that are distinct from those of the native receptors, although evidence of competitive binding was found for lacto-N-fucopentaose I with Stx2 and 2'-fucosyllactose and lacto-N-fucopentaose I with HLTB5. Taken together, the results of this study suggest that, while HMOs are expected to bind extensively to these bacterial toxins, it is unlikely that HMO binding will effectively inhibit their interactions with their cellular receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human milk oligosaccharides: Every baby needs a sugar mama
Bode, L. (2012) · Glycobiology · doi:10.1093/glycob/cws074 · Cited by 1,809 · cited 2×
“02 M) (Bode 2012).”
BackgroundInfluentialProtective effect of breast feeding against infection.
Howie, P. W., Forsyth, J. S., Ogston, S. A., Clark, A., & Florey, C. D. (1990) · BMJ · doi:10.1136/bmj.300.6716.11 · Cited by 876 · cited 2×
“Several mechanisms have been proposed to explain the protective effects of human milk, such as agglutination of pathogen cells (Howie et al. 1990), suppression of host inflammation (Ruiz-Palacios et al. 2003), modulation of host cell growth (Morrow et al. 2004) and the selective promotion of…”
BackgroundShiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
Kitov, P. I., Sadowska, J. M., Mulvey, G., Armstrong, G. D., Ling, H., Pannu, N. S., Read, R. J., & Bundle, D. R. (2000) · Nature · doi:10.1038/35001095 · Cited by 869 · cited 2×
“The ten P k trisaccharides can bind to site 2 and site 1 on each B subunit (Kitov et al. 2000); site 2 is reported to be the highest affinity binding site for the P k trisaccharide (St. Hilaire et al. 1994).”
BackgroundHuman milk is a source of lactic acid bacteria for the infant gut
Martín, R., Langa, S., Reviriego, C., Jimínez, E., Marín, M. L., Xaus, J., Fernández, L., & Rodríguez, J. M. (2003) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.09.028 · Cited by 792 · cited 1×
“…proteins, glycoproteins, free oligosaccharides (referred to as human milk oligosaccharides, HMOs) and fat globules (Lara-Villoslada et al. 2007; Martin et al. 2003), is not only an essential source of nutrition for infants but also serves to protect breast-fed infants against a variety of…”
BackgroundHUMAN MILK GLYCANS PROTECT INFANTS AGAINST ENTERIC PATHOGENS
Newburg, D. S., Ruiz-Palacios, G. M., & Morrow, A. L. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092553 · Cited by 693 · cited 2×
“…HMOs) and fat globules (Lara-Villoslada et al. 2007; Martin et al. 2003), is not only an essential source of nutrition for infants but also serves to protect breast-fed infants against a variety of infectious diseases, e.g. enteric bacterial and viral infections (Newburg et al. 2005).”
BackgroundHuman milk glycobiome and its impact on the infant gastrointestinal microbiota
Zivkovic, A. M., German, J. B., Lebrilla, C. B., & Mills, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000083107 · Cited by 679
Ruiz-Palacios, G. M., Cervantes, L. E., Ramos, P., Chavez-Munguia, B., & Newburg, D. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207744200 · Cited by 608 · cited 1×
“…to explain the protective effects of human milk, such as agglutination of pathogen cells (Howie et al. 1990), suppression of host inflammation (Ruiz-Palacios et al. 2003), modulation of host cell growth (Morrow et al. 2004) and the selective promotion of bifidobacteria growth in the…”
BackgroundHuman milk oligosaccharides are associated with protection against diarrhea in breast-fed infants
Morrow, A. L., Ruiz-Palacios, G. M., Altaye, M., Jiang, X., Lourdes Guerrero, M., Meinzen-Derr, J. K., Farkas, T., Chaturvedi, P., Pickering, L. K., & Newburg, D. S. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.04.054 · Cited by 464 · cited 1×
“…milk, such as agglutination of pathogen cells (Howie et al. 1990), suppression of host inflammation (Ruiz-Palacios et al. 2003), modulation of host cell growth (Morrow et al. 2004) and the selective promotion of bifidobacteria growth in the gastrointestinal tract of infants (Zivcovic et al. 2010).”
BackgroundStructure of the Shiga-like Toxin I B-Pentamer Complexed with an Analogue of Its Receptor Gb3,
Ling, H., Boodhoo, A., Hazes, B., Cummings, M. D., Armstrong, G. D., Brunton, J. L., & Read, R. J. (1998) · Biochemistry · doi:10.1021/bi971806n · Cited by 438 · cited 1×
“The Shiga toxins recognize the globotriaose Gb3, Gal(1-4)Gal(1-4)Glc–ceramide (Ling et al. 1998), while CT and HLT bind to the monosialylganglioside GM1, -D-Gal-(13)--D- GalNAc-14)-[α-D-Neu5Ac-(23)]--D-Gal-(14)--D-Glc-ceramide (Merrit et al. 1994).”
BackgroundBreast milk oligosaccharides: structure-function relationships in the neonate
Smilowitz, J. T., Lebrilla, C. B., Mills, D. A., German, J. B., & Freeman, S. L. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105721 · Cited by 410 · cited 3×
“Taken together, these results suggest that, regardless of the secretor status and Lewis blood group of the mother (Smilowitz et al. 2014), many of the most abundant HMOs present in a given breast milk sample will bind to bacterial exotoxins and could, potentially, have an inhibitory role against…”
BackgroundStructure-Function Relationships of Human Milk Oligosaccharides
Bode, L., & Jantscher-Krenn, E. (2012) · Advances in Nutrition · doi:10.3945/an.111.001404 · Cited by 327
Structure of Shiga Toxin Type 2 (Stx2) from Escherichia coli O157:H7
Fraser, M. E., Fujinaga, M., Cherney, M. M., Melton-Celsa, A. R., Twiddy, E. M., O'Brien, A. D., & James, M. N. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401939200 · Cited by 311 · cited 1×
“…a catalytically active A subunit and five identical B subunits that assemble into a doughnut-shaped homopentameric B5 structure that binds to the C-terminus of the A subunit and is responsible for cellular attachment (Fraser et al. 1994; Merrit et al. 1998; Fraser et al. 2004; Mudrak et al. 2010).”
BackgroundCrystal structure of the holotoxino from Shigella dysenteriae at 2.5 Å resolution
Fraser, M. E., Chernaia, M. M., Kozlov, Y. V., & James, M. N. G. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb0194-59 · Cited by 299 · cited 1×
“…a catalytically active A subunit and five identical B subunits that assemble into a doughnut-shaped homopentameric B5 structure that binds to the C-terminus of the A subunit and is responsible for cellular attachment (Fraser et al. 1994; Merrit et al. 1998; Fraser et al. 2004; Mudrak et al. 2010).”
BackgroundStructures and application of oligosaccharides in human milk
KOBATA, A. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.731 · Cited by 257 · cited 2×
“HMOs, which are structurally similar to some intestinal mucosal cell surface glycans (Kobata 2010), could act as decoys and disrupt the binding of microbial lectins to host cell receptors, thus preventing infection of the host by these organisms (Idota et al. 1995; Newburg et al. 2009; Bode et al.…”
BackgroundKitova, E. N., El-Hawiet, A., Schnier, P. D., & Klassen, J. S. (2012) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-011-0311-9 · Cited by 237 · cited 4×
“In the present work, the direct electrospray ionization mass spectrometry (ESI-MS) assay (El-Hawiet et al. 2012; Kitova et al. 2012) was used to quantify the binding of twenty commercially available HMOs to CTB5, HLTB5, Stx1B5 and Stx2 in neutral aqueous solutions at 25 °C. Results and discussion…”
MethodSelf-citationNewburg, D. S. (2009) · Journal of Animal Science · doi:10.2527/jas.2008-1347 · Cited by 233
The Predominance of Type I Oligosaccharides Is a Feature Specific to Human Breast Milk
Urashima, T., Asakuma, S., Leo, F., Fukuda, K., Messer, M., & Oftedal, O. T. (2012) · Advances in Nutrition · doi:10.3945/an.111.001412 · Cited by 217 · cited 2×
“Three of these HMOs (L7, L8 and L9) are type I (containing lacto-N-biose motif Gal-(13)--D-GlcNAc) oligosaccharides, which are the dominant type found in humans (Urashima et al. 2012).”
BackgroundMacKenzie, C. R., Hirama, T., Lee, K. K., Altman, E., & Young, N. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5533 · Cited by 206
Dissecting the Cholera Toxin−Ganglioside GM1 Interaction by Isothermal Titration Calorimetry
Turnbull, W. B., Precious, B. L., & Homans, S. W. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0378207 · Cited by 204 · cited 1×
“For CTB5 and HLTB5, the GM1 pentasaccharide L21 (Figure S1, Supplementary Data), which has affinities of >10 6 M -1 for CTB5 (Turnbull et al. 2004) and 10 8 M -1 for HLTB5 (Minke et al. 1999) was used.”
MethodHuman Milk Glycoproteins Protect Infants Against Human Pathogens
Liu, B., & Newburg, D. S. (2013) · Breastfeeding Medicine · doi:10.1089/bfm.2013.0016 · Cited by 168
Merritt, E. A., Kuhn, P., Sarfaty, S., Erbe, J. L., Holmes, R. K., & Hol, W. G. J. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2076 · Cited by 167
Sun, J., Kitova, E. N., Wang, W., & Klassen, J. S. (2006) · Analytical Chemistry · doi:10.1021/ac0522005 · Cited by 160 · cited 3×
“In all cases, a reference protein (Pref) was added to the solution in order to correct the mass spectra for the occurrence of nonspecific carbohydrate-protein binding during the ESI process (Sun et al. 2006).”
MethodSelf-citationWang, W., Kitova, E. N., & Klassen, J. S. (2003) · Analytical Chemistry · doi:10.1021/ac034300l · Cited by 157 · cited 1×
“…constants (Ka,app) for the binding of the four bacterial toxins to each of the twenty HMOs (L1 – L20) were measured by the direct ESI-MS assay (Wang et al. 2003; El-Hawiet et al. 2011; El-Hawiet et al. 2012; Kitova et al. 2012) using a minimum of two different protein and HMO concentrations…”
MethodSelf-citationZdanov, A., Li, Y., Bundle, D. R., Deng, S. J., MacKenzie, C. R., Narang, S. A., Young, N. M., & Cygler, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6423 · Cited by 153 · cited 1×
“A single chain variable fragment (scFv, MW 26 539 Da) of the monoclonal antibody Se155-4, which served as a reference protein (Pref) for the ESI-MS binding assays, was produced as described previously (Zdanov et al. 1994).”
MethodHuman Milk Contains Novel Glycans That Are Potential Decoy Receptors for Neonatal Rotaviruses
Yu, Y. Q., Lasanajak, Y., Song, X., Hu, L., Ramani, S., Mickum, M. L., Ashline, D. J., Prasad, B. V. V., Estes, M. K., Reinhold, V. N., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.039875 · Cited by 130 · cited 1×
“…cell surface glycans (Kobata 2010), could act as decoys and disrupt the binding of microbial lectins to host cell receptors, thus preventing infection of the host by these organisms (Idota et al. 1995; Newburg et al. 2009; Bode et al. 2012; Liu et al. 2013; Smilowitz et al. 2014; Yu et al. 2014).”
BackgroundGalactose‐binding site in Escherichia coli heat‐labile enterotoxin (LT) and cholera toxin (CT)
Merritt, E. A., Sixma, T. K., Kalk, K. H., van Zanten, B. A. M., & Hol, W. G. J. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00467.x · Cited by 129
Heat-Labile Enterotoxin: Beyond G M1 Binding
Mudrak, B., & Kuehn, M. J. (2010) · Toxins · doi:10.3390/toxins2061445 · Cited by 124
Interaction of the Shiga-like Toxin Type 1 B-Subunit with Its Carbohydrate Receptor
St. Hilaire, P. M., Boyd, M. K., & Toone, E. J. (1994) · Biochemistry · doi:10.1021/bi00252a011 · Cited by 121 · cited 2×
“The ten P k trisaccharides can bind to site 2 and site 1 on each B subunit (Kitov et al. 2000); site 2 is reported to be the highest affinity binding site for the P k trisaccharide (St. Hilaire et al. 1994).”
BackgroundBeneficial effects of probiotic bacteria isolated from breast milk
Lara-Villoslada, F., Olivares, M., Sierra, S., Miguel Rodríguez, J., Boza, J., & Xaus, J. (2007) · British Journal of Nutrition · doi:10.1017/s0007114507832910 · Cited by 120 · cited 2×
“Breast milk, which contains a variety of bioactive components, including proteins, glycoproteins, free oligosaccharides (referred to as human milk oligosaccharides, HMOs) and fat globules (Lara-Villoslada et al. 2007; Martin et al. 2003), is not only an essential source of nutrition for infants but also serves to prot…”
BackgroundMinke, W. E., Roach, C., Hol, W. G. J., & Verlinde, C. L. M. J. (1999) · Biochemistry · doi:10.1021/bi982649a · Cited by 110 · cited 1×
“For CTB5 and HLTB5, the GM1 pentasaccharide L21 (Figure S1, Supplementary Data), which has affinities of >10 6 M -1 for CTB5 (Turnbull et al. 2004) and 10 8 M -1 for HLTB5 (Minke et al. 1999) was used.”
MethodAngström, J., Teneberg, S., & Karlsson, K. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11859 · Cited by 107
Label-Free Absolute Quantitation of Oligosaccharides Using Multiple Reaction Monitoring
Hong, Q., Ruhaak, L. R., Totten, S. M., Smilowitz, J. T., German, J. B., & Lebrilla, C. B. (2014) · Analytical Chemistry · doi:10.1021/ac404006z · Cited by 99 · cited 2×
“Notably, these highly “promiscuous” HMOs are among the most abundant HMOs found naturally among secretors (Hong et al. 2014; Urashima et al. 2012).”
BackgroundInhibition of Cholera Toxin by Human Milk Fractions and Sialyllactose
Idota, T., Kawakami, H., Murakami, Y., & Sugawara, M. (1995) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.59.417 · Cited by 91 · cited 2×
“HMOs, which are structurally similar to some intestinal mucosal cell surface glycans (Kobata 2010), could act as decoys and disrupt the binding of microbial lectins to host cell receptors, thus preventing infection of the host by these organisms (Idota et al. 1995; Newburg et al. 2009; Bode et al. 2012; Liu et al. 201…”
BackgroundDingle, T. C., Wee, S., Mulvey, G. L., Greco, A., Kitova, E. N., Sun, J., Lin, S., Klassen, J. S., Palcic, M. M., Ng, K. K.-S., et al. (2008) · Glycobiology · doi:10.1093/glycob/cwn048 · Cited by 84 · cited 1×
“Although the protective effects of HMOs against enteric infections are widely recognized, there have been few detailed studies of the nature of the HMO interactions (Dingle et al. 2008; El-Hawiet et al. 2011; Mandal et al. 2012; Vasile et al. 2014).”
BackgroundSelf-citationBlood Group Antigen Recognition by Escherichia coli Heat-labile Enterotoxin
Holmner, Å., Askarieh, G., Ökvist, M., & Krengel, U. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.064 · Cited by 70 · cited 3×
“to a site that is distinct from the primary GM1 binding site of HLTB5, one that involves residues Gly45, Thr47, Asn94 from one subunit and Gln3 from an adjacent subunit (Holmner et al. 2007).”
BackgroundKale, R. R., McGannon, C. M., Fuller, C. A., Hatch, D. M., Flagler, M. J., Gamage, S. D., Weiss, A. A., & Iyer, S. S. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703680 · Cited by 58 · cited 2×
“Recently, the crystal structure of Stx2 bound to a disaccharide ligand -D-GalNAc-(14)--D-GalOMe (which corresponds to the terminal moiety of the O-polysaccharide of lipopolysaccharide expressed by E. coli strain O117) (Kale et al. 2008) was reported (Jacobson et al. 2014).”
BackgroundKitova, E. N., Kitov, P. I., Paszkiewicz, E., Kim, J., Mulvey, G. L., Armstrong, G. D., Bundle, D. R., & Klassen, J. S. (2007) · Glycobiology · doi:10.1093/glycob/cwm081 · Cited by 50 · cited 1×
“…while low compared to the affinity of ganglioside GM1 for CT and HLT (~10 9 M -1 ) (MacKenzie et al. 1997), are similar in magnitude to many biologically-relevant protein-carbohydrate interactions, including the P k trisaccharide interaction with Stx1 and Stx2 (~1500 M -1 ) (Kitova et al. 2007).”
BackgroundSelf-citationFuchs, G. J., Mobassaleh, M., Donohue‐Rolfe, A., Montgomery, R. K., Grand, R. J., & Keusch, G. T. (1986) · Infection and Immunity · doi:10.1128/iai.53.2.372-377.1986 · Cited by 49 · cited 1×
“For example, although the monovalent P k trisaccharide interaction with Stx1 and Stx2 is weak, binding measurements suggest that toxins bind to surface-bound glycolipid Gb3 with avidities in the 10 9 M -1 range (Fuchs et al. 1986).”
BackgroundBinding of Clostridium difficile toxins to human milk oligosaccharides
El-Hawiet, A., Kitova, E. N., Kitov, P. I., Eugenio, L., Ng, K. K.-S., Mulvey, G. L., Dingle, T. C., Szpacenko, A., Armstrong, G. D., & Klassen, J. S. (2011) · Glycobiology · doi:10.1093/glycob/cwr055 · Cited by 47 · cited 4×
“The Ka,app values reported previously for recombinant subfragments of toxins A and B (TcdA2 and TcdB1, respectively) of C. difficile are included in Table I and Figure 2 for comparison purposes (El-Hawiet et al. 2011).”
BackgroundMethodResultSelf-citationQuantifying Carbohydrate–Protein Interactions by Electrospray Ionization Mass Spectrometry Analysis
El-Hawiet, A., Kitova, E. N., & Klassen, J. S. (2012) · Biochemistry · doi:10.1021/bi300436x · Cited by 43 · cited 2×
“In the present work, the direct electrospray ionization mass spectrometry (ESI-MS) assay (El-Hawiet et al. 2012; Kitova et al. 2012) was used to quantify the binding of twenty commercially available HMOs to CTB5, HLTB5, Stx1B5 and Stx2 in neutral aqueous solutions at 25 °C. Results and discussion…”
MethodSelf-citationMandal, P. K., Branson, T. R., Hayes, E. D., Ross, J. F., Gavín, J. A., Daranas, A. H., & Turnbull, W. B. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201109068 · Cited by 42 · cited 2×
“Although the protective effects of HMOs against enteric infections are widely recognized, there have been few detailed studies of the nature of the HMO interactions (Dingle et al. 2008; El-Hawiet et al. 2011; Mandal et al. 2012; Vasile et al. 2014).”
BackgroundVasile, F., Reina, J. J., Potenza, D., Heggelund, J. E., Mackenzie, A., Krengel, U., & Bernardi, A. (2014) · Glycobiology · doi:10.1093/glycob/cwu040 · Cited by 40 · cited 2×
“ESI-MS affinity measurements The apparent association constants (Ka,app) for the binding of the four bacterial toxins to each of the twenty HMOs (L1 – L20) were measured by the direct ESI-MS assay (Wang et al. 2003; El-Hawiet et al. 2011; El-Hawiet et al. 2012; Kitova et al. 2012) using a minimum of two different prot…”
MethodBoth El Tor and classical cholera toxin bind blood group determinants
Heggelund, J. E., Haugen, E., Lygren, B., Mackenzie, A. M., Holmner, Å., Vasile, F., Reina, J. J., Bernardi, A., & Krengel, U. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.089 · Cited by 39 · cited 3×
“…(L3) and -D-GalNAc(13)-L-Fuc-(12)--D-Gal(14)[-L-Fuc- ((13)]--D-Glc (GalNAc-L3) and -D-Gal(13)-L-Fuc-(12)--D-Gal(14)[- L-Fuc-(13)]--D-Glc (Gal-L3), which are structurally similar to some HMOs, bind to CTB5 at sites distinct from the GM1 binding site (Vasile et al. 2014; Heggelund et al. 2012).”
BackgroundJacobson, J. M., Yin, J., Kitov, P. I., Mulvey, G. L., Griener, T. P., James, M. N. G., Armstrong, G. D., & Bundle, D. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.518886 · Cited by 36 · cited 1×
“Recently, the crystal structure of Stx2 bound to a disaccharide ligand -D-GalNAc-(14)--D-GalOMe (which corresponds to the terminal moiety of the O-polysaccharide of lipopolysaccharide expressed by E. coli strain O117) (Kale et al. 2008) was reported (Jacobson et al. 2014).”
BackgroundHolmner, Å., Mackenzie, A. M., Ökvist, M., Jansson, L., Lebens, M., Teneberg, S., & Krengel, U. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.11.060 · Cited by 34
Dasgupta, S., Kitov, P. I., Sadowska, J. M., & Bundle, D. R. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309436 · Cited by 16 · cited 1×
“However, because AB5 toxins, and most carbohydrate-binding exotoxins, have multiple ligand binding sites, they can engage in multivalent binding to their cellular receptors and, thus, achieve high affinity or avidity (Kitov et al. 2000; Dasgupta et al. 2014).”
BackgroundSpectroscopy of antiprotonic helium atoms and its contribution to the fundamental physical constants
Hayano, R. (2010) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.86.1 · Cited by 4
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“The high levels of competitive oligosaccharides in human milk likely provide protection to breast-fed infants against some viruses and toxins (812) (813) (814) .”
BackgroundHuman milk oligosaccharides: Shaping the infant gut microbiota and supporting health
Walsh, C., Lane, J. A., van Sinderen, D., & Hickey, R. M. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104074 · Cited by 351
Immunological Effects of Human Milk Oligosaccharides
Triantis, V., Bode, L., & van Neerven, R. J. J. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00190 · Cited by 302
“In addition to reducing the adhesion of entire bacteria, HMOs may also compete with binding of bacterial toxins and mitigate their diarrheal activity (99, 100).”
BackgroundMicrobiota‐dependent and ‐independent effects of dietary fibre on human health
Cai, Y., Folkerts, J., Folkerts, G., Maurer, M., & Braber, S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14871 · Cited by 156
Zhang, S., Li, T., Xie, J., Zhang, D., Pi, C., Zhou, L., & Yang, W. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01599-y · Cited by 155
“Concentration of HMOs in human milk Human milk is regarded as the golden standard for newborn babies [20] thanks to its variable composition of nutrients which contributes to the protection against pathogenic bacteria or viruses [31], prevention against bowel inflammation, and constructive modulation of the immune sys…”
Background
Metadata
- Authors
- El-Hawiet, A., Kitova, E. N., & Klassen, J. S.
- Affiliations
- University of Alberta (CA)
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-05-04
- Volume
- 25
- Issue
- 8
- Pages
- 845-854
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- OpenAlex
- W2306594725
- Cited by
- 51
- References
- 47
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 6 · 2023: 3 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 6 · 2018: 5 · 2017: 1 · 2016: 2
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Glycobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Alberta
- Alberta Glycomics Centre
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- human milk oligosaccharides, bacterial exotoxins, toxin binding affinity, Shiga toxin type 2, cholera toxin B subunit, heat-labile toxin, Vibrio cholerae, pathogenic Escherichia coli, 2'-fucosyllactose, lacto-N-fucopentaose I, lacto-N-tetraose, competitive binding, Clostridium difficile toxin
- MeSH terms
- Amino Sugars, Bacterial Proteins, Bacterial Toxins, Binding Sites, Carbohydrate Sequence, Cholera Toxin, Enterotoxins, Humans, Hydrogen-Ion Concentration, Milk, Human, Molecular Sequence Data, Oligosaccharides, Polysaccharides, Protein Binding, Trisaccharides, Vibrio cholerae, Clostridioides difficile, Spectrometry, Mass, Electrospray Ionization, Shiga Toxin 1, Shiga Toxin 2, Enteropathogenic Escherichia coli
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.